Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 7.47%1.2B | -3.49%431.58M | 14.81%252.91M | 20.45%382.18M | 0.95%130.04M | 20.04%1.11B | 21.74%447.19M | 2.73%220.28M | 8.88%317.29M | 136.32%128.81M |
Net income from continuing operations | -1.92%183.67M | 262.01%105.69M | -136.84%-33.67M | 2,928.96%34.62M | 17.53%77.03M | -66.69%187.26M | -76.77%29.19M | -52.63%91.39M | -99.43%1.14M | 57.13%65.54M |
Operating gains losses | -63.07%47.39M | -224.69%-66.74M | 651.23%98.29M | -71.17%20.54M | -122.00%-4.7M | 397.58%128.31M | -0.26%53.52M | 68.54%-17.83M | 169.27%71.24M | -65.94%21.37M |
Depreciation and amortization | 16.83%926.49M | 20.01%260.19M | 15.39%220M | 16.36%236.74M | 15.08%209.56M | 6.35%793.02M | 3.88%216.8M | 14.85%190.66M | 8.62%203.46M | -0.83%182.09M |
Deferred tax | -17.44%-41.42M | -17.67%-32.4M | 18.58%-8.57M | -13.22%-1.57M | -73.11%1.13M | 36.94%-35.26M | 16.37%-27.54M | -133.91%-10.53M | 83.42%-1.38M | 141.24%4.18M |
Other non cash items | 395.24%34.85M | 200.59%11.82M | 32.25%20.23M | -77.74%-4.62M | 21.82%7.42M | 108.23%7.04M | 88.76%-11.75M | -0.60%15.3M | -1.29%-2.6M | -2.51%6.09M |
Change In working capital | -78.35%-72.4M | -34.85%108.38M | -8.81%-72.93M | 188.84%66.58M | -7.02%-174.43M | 83.92%-40.59M | 57.13%166.36M | 40.71%-67.02M | 642.86%23.05M | 32.38%-162.98M |
-Change in other current assets | -11.37%-78.28M | 48.57%-32.61M | 67.23%40.44M | -2,392.76%-56.38M | 11.31%-29.74M | 68.71%-70.29M | -1,059.44%-63.4M | 199.04%24.18M | 102.75%2.46M | 68.16%-33.53M |
-Change in other current liabilities | -80.18%5.88M | -38.64%140.98M | -24.30%-113.37M | 497.13%122.96M | -11.77%-144.69M | 206.83%29.69M | 106.35%229.76M | -2.91%-91.21M | -75.83%20.59M | 4.60%-129.45M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 7.47%1.2B | -3.49%431.58M | 14.81%252.91M | 20.45%382.18M | 0.95%130.04M | 20.04%1.11B | 21.74%447.19M | 2.73%220.28M | 8.88%317.29M | 136.32%128.81M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -47.94%-2.14B | -69.80%-694.93M | -23.67%-482.08M | -16.47%-434.14M | -92.85%-525.61M | 13.01%-1.44B | -14.75%-409.27M | -24.67%-389.8M | -267.78%-372.74M | 69.37%-272.54M |
Capital expenditure reported | -33.78%-1.79B | -63.85%-617.6M | -9.55%-396.07M | -18.49%-396.76M | -43.34%-381.15M | -52.99%-1.34B | -35.31%-376.93M | -35.62%-361.54M | -97.94%-334.85M | -65.11%-265.91M |
Net PPE purchase and sale | -66.42%17.98M | 31.97%11.63M | -95.43%427K | 218.66%318K | -84.28%5.61M | -68.58%53.54M | -82.72%8.81M | -59.24%9.34M | -100.29%-268K | 566.13%35.66M |
Net intangibles purchase and sale | -962.07%-62.39M | -75,321.33%-56.57M | 25.43%-2.36M | 8.01%-1.17M | -68.46%-2.29M | 28.41%-5.87M | 96.28%-75K | -123.64%-3.17M | 55.47%-1.27M | 29.06%-1.36M |
Net business purchase and sale | -226.37%-188.25M | 49.87%-3.97M | -307.20%-50.77M | 45.83%-11.03M | -623.70%-122.48M | 93.42%-57.68M | 92.57%-7.92M | 75.87%-12.47M | -2,616.13%-20.37M | 97.64%-16.92M |
Net other investing changes | -18.31%-112.54M | 14.27%-28.43M | -51.62%-33.31M | -59.60%-25.5M | -5.37%-25.3M | -35.24%-95.12M | -62.08%-33.16M | -37.98%-21.97M | 18.97%-15.98M | -68.67%-24.01M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -47.94%-2.14B | -69.80%-694.93M | -23.67%-482.08M | -16.47%-434.14M | -92.85%-525.61M | 13.01%-1.44B | -14.75%-409.27M | -24.67%-389.8M | -267.78%-372.74M | 69.37%-272.54M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 105.97%876.75M | 989.95%237.54M | 39.10%269.91M | -88.00%7.19M | 141.56%362.1M | -33.41%425.67M | 213.27%21.79M | 66.64%194.05M | 126.11%59.93M | -80.57%149.9M |
Net issuance payments of debt | 42.10%1.68B | 88.13%404M | -13.84%326.4M | -13.31%197.79M | 108.84%749.13M | -12.78%1.18B | 39.47%214.74M | 27.68%378.81M | 417.24%228.14M | -63.20%358.71M |
Cash dividends paid | -7.03%-789.53M | -10.55%-210.03M | -5.64%-190.79M | -5.62%-190.7M | -6.17%-198.01M | -1.83%-737.65M | -5.36%-189.98M | -0.42%-180.61M | -0.38%-180.55M | -1.17%-186.51M |
Proceeds from stock option exercised by employees | -39.33%-12.2M | 30.43%6.58M | 69.95%3.37M | 33.94%7.35M | -38.68%-29.5M | -80.53%-8.75M | 22.08%5.05M | 668.97%1.98M | 30.47%5.49M | -65.62%-21.27M |
Net other financing activities | 113.96%1.16M | 561.87%37M | 2,234.53%130.93M | -205.98%-7.25M | -15,554.17%-159.52M | -155.17%-8.32M | -369.42%-8.01M | -19,068.75%-6.13M | -62.03%6.84M | 82.66%-1.02M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 105.97%876.75M | 989.95%237.54M | 39.10%269.91M | -88.00%7.19M | 141.56%362.1M | -33.41%425.67M | 213.27%21.79M | 66.64%194.05M | 126.11%59.93M | -80.57%149.9M |
Net cash flow | ||||||||||
Beginning cash position | 57.12%222.79M | -1.17%168.52M | -3.50%144.26M | 30.87%191.66M | 57.12%222.79M | -44.57%141.8M | 9.84%170.5M | 3.28%149.49M | -25.15%146.44M | -44.57%141.8M |
Current changes in cash | -166.73%-63.31M | -143.22%-25.81M | 66.13%40.74M | -1,100.89%-44.77M | -642.85%-33.47M | 201.45%94.88M | 797.35%59.71M | 34.59%24.52M | 111.33%4.47M | 109.68%6.17M |
Effect of exchange rate changes | 72.88%-3.77M | 275.16%13.01M | -368.93%-16.48M | -84.88%-2.63M | 253.71%2.34M | 32.30%-13.89M | -52.72%-7.43M | 54.61%-3.52M | 87.56%-1.42M | -143.12%-1.52M |
End cash Position | -30.11%155.72M | -30.11%155.72M | -1.17%168.52M | -3.50%144.26M | 30.87%191.66M | 57.12%222.79M | 57.12%222.79M | 9.84%170.5M | 3.28%149.49M | -25.15%146.44M |
Free cash flow | -183.87%-657.24M | -445.61%-242.58M | -0.76%-145.52M | 16.40%-15.75M | -83.01%-253.39M | -624.87%-231.53M | -19.09%70.19M | -169.62%-144.43M | -115.78%-18.84M | -27.66%-138.46M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |